Based on evidence and a humanized approach, integrative dentists envision an active role in the medicinal cannabis market

CFO supports dentists among authorized professionals to prescribe safely and with quality

Entity reinforces that personalized preparations are essential when industrialized products do not meet clinical needs

Caroline Campagnone views RDC 999/2025 favorably, allowing veterinarians authorized by CFMV to prescribe medical cannabis

Brazilian delegation led by Abiquifi participates in a mission to Colombia to exchange experiences on the regulation of cannabis cultivation, with representatives from MAPA, Anvisa, Embrapa, and major pharmaceutical industries

Regulatory advances expand access to cannabis treatments for animals, but veterinarians still face barriers in prescribing and regulating products

Anvisa's update "mirrors" the rules for controlling cannabis products directly in the list of controlled substances and defines classification for industrial inputs

Return strengthens Brazil's role in shaping global chemistry standards and boosts initiatives related to the cannabis production chain in the country

Understand the step-by-step process to acquire plant derivatives for medicinal purposes

Brazilian delegation visits pharmaceutical facilities in Colombia and participates in over 40 business meetings to strengthen partnerships and advance discussions on the regulation of cannabis cultivation

Rômison Rodrigues Mota leaves the position after a request for review delays the norm's vote; the topic will return to the regulatory agenda for 2026-2027

With limited spots available, Cannabis Connection 2025 will host the launch of the 5th Sechat Cannabis Guide and discussions on regulation, cultivation, and market

The safety and efficacy of cannabis-based products depend on an integrated chain involving chemists, biomedicals, pharmacists, and doctors — professionals who ensure, at each stage, the quality, stability, and trust in patient treatment

Public hearing discusses legal support for entities that cultivate and distribute cannabis for therapeutic purposes

Moving from Schedule I to Schedule III could unlock research, ease tax hurdles, and impact state markets

Main meeting point for the Medicinal and Industrial Cannabis industry in Latin America starts at 4pm

São Paulo hosts, on Thursday (06), the main meeting point for the Medicinal and Industrial Cannabis industry in Latin America

Statements from the medical council of RS go against national and international studies, as well as clinical practice already adopted in several countries

While Germany increases its quota to meet record demand, Australia reduces its ceiling for medicinal cannabis imports due to unused licenses

Entrepreneur and CEO of Simply Pure is running for the seat in Colorado's First District advocating for full cannabis legalization and greater regulatory fairness for the sector, as stated to the US portal MJBizDaily